Skip to main content

Table 1 Sociodemographic, clinical and laboratorial characteristics of T1D patients divided by age (Qui-square, Fisher and Mann–Whitney test)

From: Relatively young T1D adults using fixed doses of insulin have higher diabetes distress levels in a sample of patients from a Brazilian tertiary hospital

VariableAge < 25 (n = 21)
Mean ± SD/median
Age ≥ 25 (n = 49)
Mean ± SD/median
p-value
Age21.14 ± 1.65/21.0035.41 ± 7.02/34.00< 0.0001
Scholarity11.43 ± 3.03/12.0011.59 ± 3.92/12.000.8748
Years of T1D10.19 ± 6.26/11.0018.55 ± 7.94/20.00< 0.0001
Chronic complications0.76 ± 0.94/0.001.39 ± 1.15/1.000.0338
Self-monitoring3.00 ± 2.39/3.003.16 ± 2.82/3.000.9585
Cholesterol167.14 ± 38.30/169.00185.22 ± 47.08/179.000.2333
HDL-c53.52 ± 10.65/53.0052.92 ± 13.03/51.000.6124
LDL-c91.10 ± 28.00/85.00109.19 ± 45.67/98.500.1002
VLDL-c111.52 ± 80.85/87.0019.95 ± 10.65/17.000.8513
Triglycerides111.52 ± 80.85/87.00102.69 ± 67.60/86.000.6340
HbA1c10% ± 2%/11%10% ± 2%/9%0.1547
Income85.71%a; 14.29%b77.55%a; 22.45%b0.5292
  1. Income: a income reaching until 3 Brazilian minimum wages b income above 3 Brazilian minimum wages. Values expressed as mean, SD (standard deviation), median and percentage
  2. T1D: Type1 dabetes; age (years), time of T1D (years); scholarity (years of study); chronic complications (0–3); self-reported number of self-monitoring (measures/day); cholesterol: total cholesterol (mg/dl); HDL-c: HDL-cholesterol (mg/dl); LD-c: LDL-cholesterol (mg/dl); VLDL-c: VLDL-cholesterol (mg/dl); triglycerides (mg/dl); HbA1c: glycated hemoglobin (%)